ICD G70.2ORPHA:590CMS

Congenital Myasthenic Syndrome

Congenital myasthenic syndrome is a group of rare inherited conditions in which signals do not pass properly from nerves to muscles. Symptoms usually begin in infancy or early childhood and include droopy eyelids, weak eye movements, feeding and breathing difficulties, and muscle weakness that worsens with activity. Medicines that improve nerve to muscle signalling help many people, but the right medicine depends on the genetic subtype.

239
Articles
12
Trials
Updated
24 September 2026
Loading...

Common Questions

What is Congenital Myasthenic Syndrome?

Congenital myasthenic syndrome is a group of rare inherited conditions in which signals do not pass properly from nerves to muscles. Symptoms usually begin in infancy or early childhood and include droopy eyelids, weak eye movements, feeding and breathing difficulties, and muscle weakness that worsens with activity. Medicines that improve nerve to muscle signalling help many people, but the right medicine depends on the genetic subtype.

How many clinical trials are available for Congenital Myasthenic Syndrome?

RareWays currently indexes 12 clinical trials for Congenital Myasthenic Syndrome, of which 4 are actively recruiting. Trial availability changes as new studies are registered — check the trials tab for current status.

Where does the research data for Congenital Myasthenic Syndrome come from?

RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is updated regularly by Rocky, RareWays' automated research engine. All articles and trials link directly to their original sources.

Get research updates

Monthly email when new findings are published for Congenital Myasthenic Syndrome.

No spam. Unsubscribe any time. Not medical advice.

This information is for general awareness only.

For guidance specific to your situation, please speak with your healthcare team.